196 related articles for article (PubMed ID: 34166228)
1. Serine hydroxymethyltransferase 2 expression promotes tumorigenesis in rhabdomyosarcoma with 12q13-q14 amplification.
Nguyen TH; Vemu PL; Hoy GE; Boudjadi S; Chatterjee B; Shern JF; Khan J; Sun W; Barr FG
J Clin Invest; 2021 Aug; 131(15):. PubMed ID: 34166228
[TBL] [Abstract][Full Text] [Related]
2. CDK4 Amplification Reduces Sensitivity to CDK4/6 Inhibition in Fusion-Positive Rhabdomyosarcoma.
Olanich ME; Sun W; Hewitt SM; Abdullaev Z; Pack SD; Barr FG
Clin Cancer Res; 2015 Nov; 21(21):4947-59. PubMed ID: 25810375
[TBL] [Abstract][Full Text] [Related]
3. Genomic and clinical analyses of 2p24 and 12q13-q14 amplification in alveolar rhabdomyosarcoma: a report from the Children's Oncology Group.
Barr FG; Duan F; Smith LM; Gustafson D; Pitts M; Hammond S; Gastier-Foster JM
Genes Chromosomes Cancer; 2009 Aug; 48(8):661-72. PubMed ID: 19422036
[TBL] [Abstract][Full Text] [Related]
4. CDK4 is a probable target gene in a novel amplicon at 12q13.3-q14.1 in lung cancer.
Wikman H; Nymark P; Väyrynen A; Jarmalaite S; Kallioniemi A; Salmenkivi K; Vainio-Siukola K; Husgafvel-Pursiainen K; Knuutila S; Wolf M; Anttila S
Genes Chromosomes Cancer; 2005 Feb; 42(2):193-9. PubMed ID: 15543620
[TBL] [Abstract][Full Text] [Related]
5. Induction of serine hydroxymethyltransferase 2 promotes tumorigenesis and metastasis in neuroblastoma.
Clark RA; Qiao J; Jacobson JC; Chung DH
Oncotarget; 2022; 13():32-45. PubMed ID: 35018218
[TBL] [Abstract][Full Text] [Related]
6. Chromosomal and genetic imbalances in Chinese patients with rhabdomyosarcoma detected by high-resolution array comparative genomic hybridization.
Liu C; Li D; Hu J; Jiang J; Zhang W; Chen Y; Cui X; Qi Y; Zou H; Zhang W; Li F
Int J Clin Exp Pathol; 2014; 7(2):690-8. PubMed ID: 24551291
[TBL] [Abstract][Full Text] [Related]
7. Cytoplasmic SHMT2 drives the progression and metastasis of colorectal cancer by inhibiting β-catenin degradation.
Liu C; Wang L; Liu X; Tan Y; Tao L; Xiao Y; Deng P; Wang H; Deng Q; Lin Y; Jie H; Zhang H; Zhang J; Peng Y; Zhang H; Zhou Z; Sun Q; Cen X; Zhao Y
Theranostics; 2021; 11(6):2966-2986. PubMed ID: 33456583
[No Abstract] [Full Text] [Related]
8. Downregulating serine hydroxymethyltransferase 2 (SHMT2) suppresses tumorigenesis in human hepatocellular carcinoma.
Woo CC; Chen WC; Teo XQ; Radda GK; Lee PT
Oncotarget; 2016 Aug; 7(33):53005-53017. PubMed ID: 27391339
[TBL] [Abstract][Full Text] [Related]
9. Analysis of molecular cytogenetic alteration in rhabdomyosarcoma by array comparative genomic hybridization.
Liu C; Li D; Jiang J; Hu J; Zhang W; Chen Y; Cui X; Qi Y; Zou H; Zhang W; Li F
PLoS One; 2014; 9(4):e94924. PubMed ID: 24743780
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylated SHMT2 Regulates Oncogenesis Through m
Han T; Wang Y; Cheng M; Hu Q; Wan X; Huang M; Liu Y; Xun W; Xu J; Wang L; Luo R; Yuan Y; Wang K; Wang J
Adv Sci (Weinh); 2024 May; 11(18):e2307834. PubMed ID: 38460155
[TBL] [Abstract][Full Text] [Related]
11. Refined mapping of 12q13-q15 amplicons in human malignant gliomas suggests CDK4/SAS and MDM2 as independent amplification targets.
Reifenberger G; Ichimura K; Reifenberger J; Elkahloun AG; Meltzer PS; Collins VP
Cancer Res; 1996 Nov; 56(22):5141-5. PubMed ID: 8912848
[TBL] [Abstract][Full Text] [Related]
12. Amplification and overexpression of the dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 (DYRK2) gene in esophageal and lung adenocarcinomas.
Miller CT; Aggarwal S; Lin TK; Dagenais SL; Contreras JI; Orringer MB; Glover TW; Beer DG; Lin L
Cancer Res; 2003 Jul; 63(14):4136-43. PubMed ID: 12874018
[TBL] [Abstract][Full Text] [Related]
13. SHMT2 promotes the tumorigenesis of renal cell carcinoma by regulating the m6A modification of PPAT.
Huo FC; Xie M; Zhu ZM; Zheng JN; Pei DS
Genomics; 2022 Jul; 114(4):110424. PubMed ID: 35798250
[TBL] [Abstract][Full Text] [Related]
14. Deacetylation of serine hydroxymethyl-transferase 2 by SIRT3 promotes colorectal carcinogenesis.
Wei Z; Song J; Wang G; Cui X; Zheng J; Tang Y; Chen X; Li J; Cui L; Liu CY; Yu W
Nat Commun; 2018 Oct; 9(1):4468. PubMed ID: 30367038
[TBL] [Abstract][Full Text] [Related]
15. HMGA2 is the partner of MDM2 in well-differentiated and dedifferentiated liposarcomas whereas CDK4 belongs to a distinct inconsistent amplicon.
Italiano A; Bianchini L; Keslair F; Bonnafous S; Cardot-Leccia N; Coindre JM; Dumollard JM; Hofman P; Leroux A; Mainguené C; Peyrottes I; Ranchere-Vince D; Terrier P; Tran A; Gual P; Pedeutour F
Int J Cancer; 2008 May; 122(10):2233-41. PubMed ID: 18214854
[TBL] [Abstract][Full Text] [Related]
16. A different view on DNA amplifications indicates frequent, highly complex, and stable amplicons on 12q13-21 in glioma.
Fischer U; Keller A; Leidinger P; Deutscher S; Heisel S; Urbschat S; Lenhof HP; Meese E
Mol Cancer Res; 2008 Apr; 6(4):576-84. PubMed ID: 18403636
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the 12q15 MDM2 and 12q13-14 CDK4 amplicons and clinical correlations in osteosarcoma.
Mejia-Guerrero S; Quejada M; Gokgoz N; Gill M; Parkes RK; Wunder JS; Andrulis IL
Genes Chromosomes Cancer; 2010 Jun; 49(6):518-25. PubMed ID: 20196171
[TBL] [Abstract][Full Text] [Related]
18. Identification of the 12q15 amplicon within the homogeneously staining regions in the embryonal rhabdomyosarcoma cell line RMS-YM.
Kakazu N; Yamane H; Miyachi M; Shiwaku K; Hosoi H
Cytogenet Genome Res; 2014; 142(3):167-73. PubMed ID: 24480864
[TBL] [Abstract][Full Text] [Related]
19. Prognostic and therapeutic value of mitochondrial serine hydroxyl-methyltransferase 2 as a breast cancer biomarker.
Zhang L; Chen Z; Xue D; Zhang Q; Liu X; Luh F; Hong L; Zhang H; Pan F; Liu Y; Chu P; Zheng S; Lou G; Yen Y
Oncol Rep; 2016 Nov; 36(5):2489-2500. PubMed ID: 27666119
[TBL] [Abstract][Full Text] [Related]
20. MYOD-SKP2 axis boosts tumorigenesis in fusion negative rhabdomyosarcoma by preventing differentiation through p57
Pomella S; Cassandri M; D'Archivio L; Porrazzo A; Cossetti C; Phelps D; Perrone C; Pezzella M; Cardinale A; Wachtel M; Aloisi S; Milewski D; Colletti M; Sreenivas P; Walters ZS; Barillari G; Di Giannatale A; Milano GM; De Stefanis C; Alaggio R; Rodriguez-Rodriguez S; Carlesso N; Vakoc CR; Velardi E; Schafer BW; Guccione E; Gatz SA; Wasti A; Yohe M; Ignatius M; Quintarelli C; Shipley J; Miele L; Khan J; Houghton PJ; Marampon F; Gryder BE; De Angelis B; Locatelli F; Rota R
Nat Commun; 2023 Dec; 14(1):8373. PubMed ID: 38102140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
